← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 28, 2015Last known activity
Sep 6, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (18 distinct, 13 trials)
Phase 4 (3 own, 0 via acquisition)
Other trials (15 own, 0 via acquisition)
Recent trials (14)
- NCT06012669Lead sponsorN/ASep 6, 2023
- NCT05540405Lead sponsorN/AJan 31, 2023
- NCT05456477Lead sponsorN/AOct 7, 2022
- NCT05438173Lead sponsorN/AJul 11, 2022
- NCT05287906Lead sponsorN/AApr 15, 2022
- NCT04990817Lead sponsorN/AJun 18, 2021
- NCT04556032Lead sponsorN/ASep 9, 2020
- NCT03562468CollaboratorN/AJun 13, 2018
- NCT03443076Lead sponsorPhase 4Feb 16, 2018
- NCT03202654Lead sponsorN/AJun 22, 2017
- NCT03126981Lead sponsorN/AApr 20, 2017
- NCT03118583Lead sponsorN/AMar 15, 2017
- NCT02924558Lead sponsorN/AFeb 28, 2015
- NCT02924558Overall official - principal investigatorN/AFeb 28, 2015
Details
- Founded
- Glen Ellyn, IL, US
- Last known activity
- Sep 6, 2023